Matthew Johnson - Publications

Johns Hopkins University Johns Hopkins University, Baltimore, MD 

98 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Pacek LR, Berry MS, Rass O, Mercincavage M, McClernon FJ, Johnson MW. Graphic Warning Labels Affect Hypothetical Cigarette Purchasing Behavior among Smokers Living with HIV. International Journal of Environmental Research and Public Health. 16. PMID 31547374 DOI: 10.3390/ijerph16183380  1
2019 Dolan SB, Berry MS, Johnson PS, Johnson MW. Potential for limited reinforcing and abuse-related subjective effects of intranasal oxytocin. Journal of Psychopharmacology (Oxford, England). 269881119867607. PMID 31475622 DOI: 10.1177/0269881119867607  1
2019 Johnson MW, Bruner NR, Johnson PS, Silverman K, Berry MS. Randomized controlled trial of d-cycloserine in cocaine dependence: Effects on contingency management and cue-induced cocaine craving in a naturalistic setting. Experimental and Clinical Psychopharmacology. PMID 31368770 DOI: 10.1037/pha0000306  1
2019 Sweeney MM, Berry MS, Johnson PS, Herrmann ES, Meredith SE, Johnson MW. Demographic and sexual risk predictors of delay discounting of condom-protected sex. Psychology & Health. 1-21. PMID 31311321 DOI: 10.1080/08870446.2019.1631306  1
2019 Garcia-Romeu A, Davis AK, Erowid F, Erowid E, Griffiths RR, Johnson MW. Cessation and reduction in alcohol consumption and misuse after psychedelic use. Journal of Psychopharmacology (Oxford, England). 269881119845793. PMID 31084460 DOI: 10.1177/0269881119845793  1
2019 Griffiths RR, Hurwitz ES, Davis AK, Johnson MW, Jesse R. Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT. Plos One. 14: e0214377. PMID 31013281 DOI: 10.1371/journal.pone.0214377  1
2018 Sweeney MM, Rass O, DiClemente C, Schacht RL, Vo HT, Fishman MJ, Leoutsakos JS, Mintzer MZ, Johnson MW. Working Memory Training for Adolescents With Cannabis Use Disorders: A Randomized Controlled Trial. Journal of Child & Adolescent Substance Abuse. 27: 211-226. PMID 30524179 DOI: 10.1080/1067828X.2018.1451793  1
2018 Johnson MW, Hendricks PS, Barrett FS, Griffiths RR. Classic Psychedelics: An integrative review of epidemiology, mystical experience, brain network function, and therapeutics. Pharmacology & Therapeutics. PMID 30521880 DOI: 10.1016/j.pharmthera.2018.11.010  1
2018 Barrett FS, Carbonaro TM, Hurwitz E, Johnson MW, Griffiths RR. Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition. Psychopharmacology. PMID 30062577 DOI: 10.1007/s00213-018-4981-x  1
2018 Noorani T, Garcia-Romeu A, Swift TC, Griffiths RR, Johnson MW. Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts. Journal of Psychopharmacology (Oxford, England). 269881118780612. PMID 29938565 DOI: 10.1177/0269881118780612  1
2018 Johnson MW, Griffiths RR, Hendricks PS, Henningfield JE. The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act. Neuropharmacology. PMID 29753748 DOI: 10.1016/j.neuropharm.2018.05.012  1
2018 Pacek LR, McClernon FJ, Rass O, Sweizter MM, Johnson MW. Perceived risk of developing smoking-related disease among persons living with HIV. Aids Care. 1-6. PMID 29682993 DOI: 10.1080/09540121.2018.1466985  1
2018 Berry MS, Johnson PS, Collado A, Loya JM, Yi R, Johnson MW. Sexual Probability Discounting: A Mechanism for Sexually Transmitted Infection Among Undergraduate Students. Archives of Sexual Behavior. PMID 29582269 DOI: 10.1007/s10508-018-1155-1  1
2017 Carbonaro TM, Johnson MW, Hurwitz E, Griffiths RR. Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences. Psychopharmacology. PMID 29116367 DOI: 10.1007/s00213-017-4769-4  1
2017 Griffiths RR, Johnson MW, Richards WA, Richards BD, Jesse R, MacLean KA, Barrett FS, Cosimano MP, Klinedinst MA. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. Journal of Psychopharmacology (Oxford, England). 269881117731279. PMID 29020861 DOI: 10.1177/0269881117731279  1
2017 Berry MS, Johnson MW. Does being drunk or high cause HIV sexual risk behavior? A systematic review of drug administration studies. Pharmacology, Biochemistry, and Behavior. PMID 28843425 DOI: 10.1016/j.pbb.2017.08.009  1
2017 Barrett FS, Johnson MW, Griffiths RR. Neuroticism is associated with challenging experiences with psilocybin mushrooms. Personality and Individual Differences. 117: 155-160. PMID 28781400 DOI: 10.1016/j.paid.2017.06.004  1
2017 Herrmann ES, Johnson PS, Bruner NR, Vandrey R, Johnson MW. Morning administration of oral methamphetamine dose-dependently disrupts nighttime sleep in recreational stimulant users. Drug and Alcohol Dependence. 178: 291-295. PMID 28686987 DOI: 10.1016/j.drugalcdep.2017.05.013  1
2017 Andrew Tompkins D, Huhn AS, Johnson PS, Smith MT, Strain EC, Edwards RR, Johnson MW. "To take or not to take: The association between perceived addiction risk, expected analgesic response, and likelihood of trying novel pain relievers in self-identified chronic pain patients". Addiction (Abingdon, England). PMID 28645137 DOI: 10.1111/add.13922  1
2017 Johnson MW, Johnson PS, Rass O, Pacek LR. Behavioral economic substitutability of e-cigarettes, tobacco cigarettes, and nicotine gum. Journal of Psychopharmacology (Oxford, England). 269881117711921. PMID 28612651 DOI: 10.1177/0269881117711921  1
2017 Johnson MW, Griffiths RR. Potential Therapeutic Effects of Psilocybin. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 28585222 DOI: 10.1007/s13311-017-0542-y  1
2017 Pacek LR, Rass O, Johnson MW. Positive smoking cessation-related interactions with HIV care providers increase the likelihood of interest in cessation among HIV-positive cigarette smokers. Aids Care. 1-6. PMID 28535687 DOI: 10.1080/09540121.2017.1330532  1
2017 Johnson MW, Garcia-Romeu A, Johnson PS, Griffiths RR. An online survey of tobacco smoking cessation associated with naturalistic psychedelic use. Journal of Psychopharmacology (Oxford, England). 269881116684335. PMID 28095732 DOI: 10.1177/0269881116684335  1
2016 Johnson MW, Herrmann ES, Sweeney MM, LeComte RS, Johnson PS. Cocaine administration dose-dependently increases sexual desire and decreases condom use likelihood: The role of delay and probability discounting in connecting cocaine with HIV. Psychopharmacology. PMID 27921140 DOI: 10.1007/s00213-016-4493-5  1
2016 Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology (Oxford, England). 30: 1181-1197. PMID 27909165 DOI: 10.1177/0269881116675513  1
2016 Barrett FS, Bradstreet MP, Leoutsakos JS, Johnson MW, Griffiths RR. The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. Journal of Psychopharmacology (Oxford, England). PMID 27856683 DOI: 10.1177/0269881116678781  1
2016 Pacek LR, Rass O, Johnson MW. Knowledge about nicotine among HIV-positive smokers: Implications for tobacco regulatory science policy. Addictive Behaviors. 65: 81-86. PMID 27792909 DOI: 10.1016/j.addbeh.2016.10.008  1
2016 Collado A, Johnson PS, Loya JM, Johnson MW, Yi R. Discounting of Condom-Protected Sex as a Measure of High Risk for Sexually Transmitted Infection Among College Students. Archives of Sexual Behavior. PMID 27699562 DOI: 10.1007/s10508-016-0836-x  1
2016 Sweeney MM, Rass O, Johnson PS, Strain EC, Berry MS, Vo HT, Fishman MJ, Munro CA, Rebok GW, Mintzer MZ, Johnson MW. Initial feasibility and validity of a prospective memory training program in a substance use treatment population. Experimental and Clinical Psychopharmacology. 24: 390-399. PMID 27690506 DOI: 10.1037/pha0000091  1
2016 Dunn KE, Barrett FS, Herrmann ES, Plebani JG, Sigmon SC, Johnson MW. Behavioral risk assessment for infectious diseases (BRAID): Self-report instrument to assess injection and noninjection risk behaviors in substance users. Drug and Alcohol Dependence. 168: 69-75. PMID 27615403 DOI: 10.1016/j.drugalcdep.2016.07.032  1
2016 Carbonaro TM, Bradstreet MP, Barrett FS, MacLean KA, Jesse R, Johnson MW, Griffiths RR. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology (Oxford, England). PMID 27578767 DOI: 10.1177/0269881116662634  1
2016 Koffarnus MN, Johnson MW, Thompson-Lake DG, Wesley MJ, Lohrenz T, Montague PR, Bickel WK. Cocaine-dependent adults and recreational cocaine users are more likely than controls to choose immediate unsafe sex over delayed safer sex. Experimental and Clinical Psychopharmacology. 24: 297-304. PMID 27454677 DOI: 10.1037/pha0000080  1
2016 Johnson MW, Garcia-Romeu A, Griffiths RR. Long-term follow-up of psilocybin-facilitated smoking cessation. The American Journal of Drug and Alcohol Abuse. 1-6. PMID 27441452 DOI: 10.3109/00952990.2016.1170135  1
2016 Sheffer CE, Mackillop J, Fernandez A, Christensen D, Bickel WK, Johnson MW, Panissidi L, Pittman J, Franck CT, Williams J, Mathew M. Initial examination of priming tasks to decrease delay discounting. Behavioural Processes. PMID 27179761 DOI: 10.1016/j.beproc.2016.05.002  1
2016 Johnson PS, Sweeney MM, Herrmann ES, Johnson MW. Alcohol Increases Delay and Probability Discounting of Condom-Protected Sex: A Novel Vector for Alcohol-Related HIV Transmission. Alcoholism, Clinical and Experimental Research. PMID 27129419 DOI: 10.1111/acer.13079  1
2016 Tompkins DA, Johnson PS, Smith MT, Strain EC, Edwards RR, Johnson MW. Temporal preference in individuals reporting chronic pain: discounting of delayed pain-related and monetary outcomes. Pain. PMID 27075431 DOI: 10.1097/j.pain.0000000000000576  1
2016 Meredith SE, Sweeney MM, Johnson PS, Johnson MW, Griffiths RR. Weekly Energy Drink Use Is Positively Associated with Delay Discounting and Risk Behavior in a Nationwide Sample of Young Adults. Journal of Caffeine Research. 6: 10-19. PMID 26989563 DOI: 10.1089/jcr.2015.0024  1
2016 Johnson MW, MacLean KA, Caspers MJ, Prisinzano TE, Griffiths RR. Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humans. Journal of Psychopharmacology (Oxford, England). PMID 26880225 DOI: 10.1177/0269881116629125  1
2016 Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J, Ballester MR, Garrido M, González M, Claramunt J, Barker S, Lomnicka I, Waguespack M, Johnson MW, Griffiths RR, et al. Naltrexone but not ketanserin antagonizes the subjective, cardiovascular and neuroendocrine effects of salvinorin-A in humans. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26874330 DOI: 10.1093/ijnp/pyw016  1
2015 George A, Lang G, Johnson M, Ridge A, de Silva AM, Ajwani S, Bhole S, Blinkhorn A, Dahlen HG, Ellis S, Yeo A, Langdon R, Carpenter L, Heilbrunn-Lang A. The evaluation of an oral health education program for midwives in Australia. Women and Birth : Journal of the Australian College of Midwives. PMID 26552339 DOI: 10.1016/j.wombi.2015.10.004  0.32
2015 Wilkes L, Cowin L, Johnson M. The reasons students choose to undertake a nursing degree. Collegian (Royal College of Nursing, Australia). 22: 259-65. PMID 26552196 DOI: 10.1016/j.colegn.2014.01.003  0.32
2015 Barrett FS, Johnson MW, Griffiths RR. Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. Journal of Psychopharmacology (Oxford, England). 29: 1182-90. PMID 26442957 DOI: 10.1177/0269881115609019  1
2015 Rass O, Schacht RL, Buckheit K, Johnson MW, Strain EC, Mintzer MZ. A randomized controlled trial of the effects of working memory training in methadone maintenance patients. Drug and Alcohol Dependence. 156: 38-46. PMID 26404954 DOI: 10.1016/j.drugalcdep.2015.08.012  1
2015 Hendricks PS, Johnson MW, Griffiths RR. Psilocybin, psychological distress, and suicidality. Journal of Psychopharmacology (Oxford, England). 29: 1041-3. PMID 26395582 DOI: 10.1177/0269881115598338  1
2015 Rass O, Pacek LR, Johnson PS, Johnson MW. Characterizing Use Patterns and Perceptions of Relative Harm in Dual Users of Electronic and Tobacco Cigarettes. Experimental and Clinical Psychopharmacology. PMID 26389638 DOI: 10.1037/pha0000050  1
2015 Tupper KW, Wood E, Yensen R, Johnson MW. Psychedelic medicine: a re-emerging therapeutic paradigm. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 187: 1054-9. PMID 26350908 DOI: 10.1503/cmaj.141124  1
2015 Duke AN, Johnson MW, Reissig CJ, Griffiths RR. Nicotine reinforcement in never-smokers. Psychopharmacology. PMID 26345343 DOI: 10.1007/s00213-015-4053-4  1
2015 Herrmann ES, Johnson PS, Johnson MW. Examining Delay Discounting of Condom-Protected Sex Among Men Who Have Sex with Men Using Crowdsourcing Technology. Aids and Behavior. PMID 26066395 DOI: 10.1007/s10461-015-1107-x  1
2015 Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J, Ballester MR, Garrido M, González M, Claramunt J, Barker S, Johnson MW, Griffiths RR, Riba J. Salvinorin-A induces intense dissociative effects, blocking external sensory perception and modulating interoception and sense of body ownership in humans. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26047623 DOI: 10.1093/ijnp/pyv065  1
2015 Johnson MW, Johnson PS, Herrmann ES, Sweeney MM. Delay and probability discounting of sexual and monetary outcomes in individuals with cocaine use disorders and matched controls. Plos One. 10: e0128641. PMID 26017273 DOI: 10.1371/journal.pone.0128641  1
2015 Heilbrunn-Lang AY, de Silva AM, Lang G, George A, Ridge A, Johnson M, Bhole S, Gilmour C. Midwives' perspectives of their ability to promote the oral health of pregnant women in Victoria, Australia. Bmc Pregnancy and Childbirth. 15: 110. PMID 25943399 DOI: 10.1186/s12884-015-0536-x  0.32
2015 Bogenschutz MP, Johnson MW. Classic hallucinogens in the treatment of addictions. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 25784600 DOI: 10.1016/j.pnpbp.2015.03.002  1
2015 Hendricks PS, Thorne CB, Clark CB, Coombs DW, Johnson MW. Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. Journal of Psychopharmacology (Oxford, England). 29: 280-8. PMID 25586402 DOI: 10.1177/0269881114565653  1
2015 Sessa B, Johnson MW. Can psychedelic compounds play a part in drug dependence therapy? The British Journal of Psychiatry : the Journal of Mental Science. 206: 1-3. PMID 25561484 DOI: 10.1192/bjp.bp.114.148031  1
2015 Dariotis JK, Johnson MW. Sexual discounting among high-risk youth ages 18-24: implications for sexual and substance use risk behaviors. Experimental and Clinical Psychopharmacology. 23: 49-58. PMID 25545764 DOI: 10.1037/a0038399  1
2015 Johnson PS, Herrmann ES, Johnson MW. Opportunity costs of reward delays and the discounting of hypothetical money and cigarettes. Journal of the Experimental Analysis of Behavior. 103: 87-107. PMID 25388973 DOI: 10.1002/jeab.110  1
2015 Rass O, Umbricht A, Bigelow GE, Strain EC, Johnson MW, Mintzer MZ. Topiramate impairs cognitive function in methadone-maintained individuals with concurrent cocaine dependence. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 29: 237-46. PMID 25365653 DOI: 10.1037/adb0000027  1
2015 Johnson MW, Bruner NR, Johnson PS. Cocaine dependent individuals discount future rewards more than future losses for both cocaine and monetary outcomes. Addictive Behaviors. 40: 132-6. PMID 25260200 DOI: 10.1016/j.addbeh.2014.08.011  1
2014 Garcia-Romeu A, Griffiths RR, Johnson MW. Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. Current Drug Abuse Reviews. 7: 157-64. PMID 25563443  1
2014 Johnson PS, Johnson MW. Investigation of "bath salts" use patterns within an online sample of users in the United States. Journal of Psychoactive Drugs. 46: 369-78. PMID 25364987 DOI: 10.1080/02791072.2014.962717  1
2014 Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR. Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology (Oxford, England). 28: 983-92. PMID 25213996 DOI: 10.1177/0269881114548296  1
2014 Herrmann ES, Hand DJ, Johnson MW, Badger GJ, Heil SH. Examining delay discounting of condom-protected sex among opioid-dependent women and non-drug-using control women. Drug and Alcohol Dependence. 144: 53-60. PMID 25190049 DOI: 10.1016/j.drugalcdep.2014.07.026  1
2014 Bickel WK, Johnson MW, Koffarnus MN, MacKillop J, Murphy JG. The behavioral economics of substance use disorders: reinforcement pathologies and their repair. Annual Review of Clinical Psychology. 10: 641-77. PMID 24679180 DOI: 10.1146/annurev-clinpsy-032813-153724  1
2013 Vandrey R, Johnson MW, Johnson PS, Khalil MA. Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace. Adolescent Psychiatry (Hilversum, Netherlands). 3: 123-134. PMID 24921061  1
2013 Caspers MJ, Williams TD, Lovell KM, Lozama A, Butelman ER, Kreek MJ, Johnson M, Griffiths R, Maclean K, Prisinzano TE. LC-MS/MS quantification of salvinorin A from biological fluids. Analytical Methods : Advancing Methods and Applications. 5. PMID 24416081 DOI: 10.1039/C3AY40810H  1
2013 Johnson MW, Griffiths RR. Comparative abuse liability of GHB and ethanol in humans. Experimental and Clinical Psychopharmacology. 21: 112-23. PMID 23421353 DOI: 10.1037/a0031692  1
2013 MacLean KA, Johnson MW, Reissig CJ, Prisinzano TE, Griffiths RR. Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects. Psychopharmacology. 226: 381-92. PMID 23135605 DOI: 10.1007/s00213-012-2912-9  1
2013 Carter LP, Reissig CJ, Johnson MW, Klinedinst MA, Griffiths RR, Mintzer MZ. Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans. Drug and Alcohol Dependence. 128: 206-13. PMID 22989498 DOI: 10.1016/j.drugalcdep.2012.08.025  1
2012 Maclean KA, Leoutsakos JM, Johnson MW, Griffiths RR. Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin. Journal For the Scientific Study of Religion. 51: 721-737. PMID 23316089 DOI: 10.1111/j.1468-5906.2012.01685.x  1
2012 Reissig CJ, Carter LP, Johnson MW, Mintzer MZ, Klinedinst MA, Griffiths RR. High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens. Psychopharmacology. 223: 1-15. PMID 22526529 DOI: 10.1007/s00213-012-2680-6  1
2012 Johnson MW, Sewell RA, Griffiths RR. Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers. Drug and Alcohol Dependence. 123: 132-40. PMID 22129843 DOI: 10.1016/j.drugalcdep.2011.10.029  1
2011 MacLean KA, Johnson MW, Griffiths RR. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Journal of Psychopharmacology (Oxford, England). 25: 1453-61. PMID 21956378 DOI: 10.1177/0269881111420188  1
2011 Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, Jesse R. Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology. 218: 649-65. PMID 21674151 DOI: 10.1007/s00213-011-2358-5  1
2011 Johnson MW, MacLean KA, Reissig CJ, Prisinzano TE, Griffiths RR. Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum. Drug and Alcohol Dependence. 115: 150-5. PMID 21131142 DOI: 10.1016/j.drugalcdep.2010.11.005  1
2010 Jefferies D, Johnson M, Griffiths R, Arthurs K, Beard D, Chen T, Edgetton-Winn M, Hecimovic T, Hughes M, Linten K, Maddox J, McCaul D, Robson K, Scott S, Zarkos T. Engaging clinicians in evidence based policy development: the case of nursing documentation. Contemporary Nurse. 35: 254-64. PMID 20950205 DOI: 10.5172/conu.2010.35.2.254  0.32
2010 Johnson MW, Strain EC, Griffiths RR. Effects of oral caffeine pretreatment on response to intravenous nicotine and cocaine. Experimental and Clinical Psychopharmacology. 18: 305-15. PMID 20695686 DOI: 10.1037/a0020509  1
2010 Jefferies D, Johnson M, Griffiths R. A meta-study of the essentials of quality nursing documentation. International Journal of Nursing Practice. 16: 112-24. PMID 20487056 DOI: 10.1111/j.1440-172X.2009.01815.x  1
2010 Johnson MW, Bickel WK, Baker F, Moore BA, Badger GJ, Budney AJ. Delay discounting in current and former marijuana-dependent individuals. Experimental and Clinical Psychopharmacology. 18: 99-107. PMID 20158299 DOI: 10.1037/a0018333  1
2009 Tran DT, Stone AM, Fernandez RS, Griffiths RD, Johnson M. Does implementation of clinical practice guidelines change nurses' screening for alcohol and other substance use? Contemporary Nurse. 33: 13-9. PMID 19715491 DOI: 10.5555/conu.33.1.13  0.32
2009 Tran DT, Stone AM, Fernandez RS, Griffiths RD, Johnson M. Changes in general nurses' knowledge of alcohol and substance use and misuse after education. Perspectives in Psychiatric Care. 45: 128-39. PMID 19366423 DOI: 10.1111/j.1744-6163.2009.00213.x  0.32
2008 Yi R, Johnson MW, Giordano LA, Landes RD, Badger GJ, Bickel WK. THE EFFECTS OF REDUCED CIGARETTE SMOKING ON DISCOUNTING FUTURE REWARDS: AN INITIAL EVALUATION. The Psychological Record. 58: 163-174. PMID 23825867  1
2008 Griffiths R, Richards W, Johnson M, McCann U, Jesse R. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Journal of Psychopharmacology (Oxford, England). 22: 621-32. PMID 18593735 DOI: 10.1177/0269881108094300  1
2008 Johnson M, Richards W, Griffiths R. Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology (Oxford, England). 22: 603-20. PMID 18593734 DOI: 10.1177/0269881108093587  1
2008 Johnson MW, Bickel WK. An algorithm for identifying nonsystematic delay-discounting data. Experimental and Clinical Psychopharmacology. 16: 264-74. PMID 18540786 DOI: 10.1037/1064-1297.16.3.264  1
2007 Johnson MW, Bickel WK, Baker F. Moderate drug use and delay discounting: a comparison of heavy, light, and never smokers. Experimental and Clinical Psychopharmacology. 15: 187-94. PMID 17469942 DOI: 10.1037/1064-1297.15.2.187  1
2006 Johnson MW, Suess PE, Griffiths RR. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects. Archives of General Psychiatry. 63: 1149-57. PMID 17015817 DOI: 10.1001/archpsyc.63.10.1149  1
2006 Johnson MW, Bickel WK. Replacing relative reinforcing efficacy with behavioral economic demand curves. Journal of the Experimental Analysis of Behavior. 85: 73-93. PMID 16602377 DOI: 10.1901/jeab.2006.102-04  1
2006 Heil SH, Johnson MW, Higgins ST, Bickel WK. Delay discounting in currently using and currently abstinent cocaine-dependent outpatients and non-drug-using matched controls. Addictive Behaviors. 31: 1290-4. PMID 16236455 DOI: 10.1016/j.addbeh.2005.09.005  1
2005 Yi R, Johnson MW, Bickel WK. Relationship between cooperation in an iterated prisoner's dilemma game and the discounting of hypothetical outcomes. Learning & Behavior. 33: 324-36. PMID 16396079  1
2005 Griffiths RR, Johnson MW. Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds. The Journal of Clinical Psychiatry. 66: 31-41. PMID 16336040  1
2005 Johnson M, Griffiths R, Piper M, Langdon R. Risk factors for an untoward medication event among elders in community-based nursing caseloads in Australia. Public Health Nursing (Boston, Mass.). 22: 36-44. PMID 15670323 DOI: 10.1111/j.0737-1209.2005.22106.x  1
2004 Griffiths R, Johnson M, Piper M, Langdon R. A nursing intervention for the quality use of medicines by elderly community clients. International Journal of Nursing Practice. 10: 166-76. PMID 15265227 DOI: 10.1111/j.1440-172X.2004.00476.x  1
2004 Johnson MW, Bickel WK, Kirshenbaum AP. Substitutes for tobacco smoking: a behavioral economic analysis of nicotine gum, denicotinized cigarettes, and nicotine-containing cigarettes. Drug and Alcohol Dependence. 74: 253-64. PMID 15194203 DOI: 10.1016/j.drugalcdep.2003.12.012  1
2003 Baker F, Johnson MW, Bickel WK. Decision-making in state lotteries: half now or all of it later? Psychonomic Bulletin & Review. 10: 965-70. PMID 15000546  1
2003 Baker F, Johnson MW, Bickel WK. Delay discounting in current and never-before cigarette smokers: similarities and differences across commodity, sign, and magnitude. Journal of Abnormal Psychology. 112: 382-92. PMID 12943017 DOI: 10.1037/0021-843X.112.3.382  1
2003 Johnson MW, Bickel WK. The behavioral economics of cigarette smoking: The concurrent presence of a substitute and an independent reinforcer. Behavioural Pharmacology. 14: 137-44. PMID 12658074 DOI: 10.1097/01.fbp.0000063266.43827.42  1
2002 Johnson MW, Bickel WK. Within-subject comparison of real and hypothetical money rewards in delay discounting. Journal of the Experimental Analysis of Behavior. 77: 129-46. PMID 11936247 DOI: 10.1901/jeab.2002.77-129  1
2001 Johnson M, Griffiths R. Developing evidence-based clinicians. International Journal of Nursing Practice. 7: 109-18. PMID 11811313  1
Show low-probability matches.